Veteran CFO appointment underscores the Company’s commitment to building a strong leadership team as it advances its clinical ...

With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with ...

Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma", "Nasus" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative ...

Alongside scientific innovation, ESMO 2025 emphasised the need for global collaboration in regulatory alignment and clinical ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited ("Advanz Pharma"), a U ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Indeed, creating a ‘smart investment strategy’ offers wide-ranging benefits – healthcare providers can innovate, patients ...

In 2026 and beyond, I predict that more pharmaceutical companies will use AI in their HCP marketing workflows—namely, ...

Global Biotech is surging as policy fears fade and innovation takes centre stage. Here’s what’s driving the comeback into ...

Alvotech (ALVO) and Advanz Pharma on Thursday said that the European Commission has granted marketing authorizations in the ...

This session will explore best practices for sourcing and managing comparator products in clinical trials. It is designed to ...